MUFG Securities EMEA plc grew its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON – Free Report) by 115.2% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,235 shares of the biotechnology company’s stock after purchasing an additional 1,732 shares during the period. MUFG Securities EMEA plc’s holdings in Axon Enterprise were worth $1,837,000 as of its most recent filing with the Securities and Exchange Commission.
Several other large investors also recently made changes to their positions in the business. Forsta AP Fonden boosted its holdings in shares of Axon Enterprise by 81.7% in the fourth quarter. Forsta AP Fonden now owns 29,260 shares of the biotechnology company’s stock worth $16,618,000 after buying an additional 13,160 shares during the period. Norges Bank acquired a new position in shares of Axon Enterprise in the fourth quarter worth about $515,764,000. Eurizon Capital SGR S.p.A. acquired a new position in shares of Axon Enterprise in the fourth quarter worth about $13,116,000. Fideuram Asset Management Ireland dac acquired a new position in shares of Axon Enterprise in the fourth quarter worth about $569,000. Finally, Mitsubishi UFJ Morgan Stanley Securities Co. Ltd. acquired a new position in shares of Axon Enterprise in the fourth quarter worth about $141,000. Institutional investors own 79.08% of the company’s stock.
Analyst Upgrades and Downgrades
Several research analysts have commented on AXON shares. Zacks Research upgraded shares of Axon Enterprise from a “hold” rating to a “strong-buy” rating in a report on Tuesday, May 19th. Piper Sandler reduced their price objective on Axon Enterprise from $690.00 to $674.00 and set an “overweight” rating for the company in a research note on Thursday, May 7th. Morgan Stanley set a $600.00 price objective on Axon Enterprise in a research note on Thursday, May 7th. Weiss Ratings raised Axon Enterprise from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday, May 8th. Finally, JPMorgan Chase & Co. increased their price objective on Axon Enterprise from $750.00 to $755.00 and gave the stock an “overweight” rating in a research note on Thursday, May 7th. One analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat.com, Axon Enterprise currently has a consensus rating of “Moderate Buy” and a consensus target price of $712.75.
Axon Enterprise Stock Performance
Shares of NASDAQ AXON opened at $476.88 on Tuesday. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.93 and a current ratio of 2.27. The firm has a market cap of $38.44 billion, a price-to-earnings ratio of 191.52, a P/E/G ratio of 8.16 and a beta of 1.44. The business’s 50-day simple moving average is $407.02 and its 200-day simple moving average is $493.35. Axon Enterprise, Inc has a 52 week low of $339.01 and a 52 week high of $885.91.
Axon Enterprise (NASDAQ:AXON – Get Free Report) last issued its quarterly earnings data on Wednesday, May 6th. The biotechnology company reported $1.61 EPS for the quarter, beating analysts’ consensus estimates of $1.60 by $0.01. The business had revenue of $807.35 million for the quarter, compared to analyst estimates of $778.91 million. Axon Enterprise had a return on equity of 3.78% and a net margin of 6.90%.The firm’s revenue for the quarter was up 33.7% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.47 EPS. As a group, equities research analysts expect that Axon Enterprise, Inc will post 1.82 earnings per share for the current fiscal year.
Insider Buying and Selling at Axon Enterprise
In other Axon Enterprise news, Director Erika Nardini sold 198 shares of the firm’s stock in a transaction that occurred on Tuesday, March 17th. The stock was sold at an average price of $506.58, for a total value of $100,302.84. Following the sale, the director owned 1,946 shares of the company’s stock, valued at $985,804.68. This trade represents a 9.24% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Jeri Williams sold 157 shares of the firm’s stock in a transaction that occurred on Tuesday, March 17th. The shares were sold at an average price of $490.00, for a total value of $76,930.00. Following the completion of the sale, the director directly owned 1,159 shares in the company, valued at $567,910. This trade represents a 11.93% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 2,355 shares of company stock valued at $977,233 in the last 90 days. 4.20% of the stock is currently owned by insiders.
Axon Enterprise Profile
Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.
Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.
Read More
- Five stocks we like better than Axon Enterprise
- Why These Three Big Buybacks Are Sending Very Different Signals to Investors
- Drone Stocks Soar As Pentagon Considers Funding, Including a Trump-Linked Name
- Braze Blazes Ahead on Q1 2027 Earnings Beat, Raised Guidance
- Are the 3 Newest Members of the $1 Trillion Market Cap Club the Latest Sign of an AI Bubble?
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.
